The orthostatic hypotension market has witnessed significant growth over the past few years owing to the rising prevalence of neurological disorders and hypertension. Orthostatic hypotension, also known as postural hypotension, is a form of low blood pressure that occurs when a person stands up from lying or sitting position. It results from the inability of the body to regulate blood pressure properly when changing position. The condition can cause dizziness, fainting, blurred vision and weakness. The market is primarily driven by factors such as the growing geriatric population, rising cases of neurovascular conditions, increasing prevalence of hypertension and diabetes.
The orthostatic hypotension market is estimated to be valued at USD 1.93 Bn in 2024 and is expected to reach USD 3.15 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.
Key Takeaways
Key players: Key players operating in the orthostatic hypotension market are Mylan, Amneal Pharmaceuticals, Pfizer, Novartis, Hikma Pharmaceuticals, Accord Healthcare, Viatris and Sun Pharmaceutical Industries.
Growing demand: The market is witnessing growing demand for effective drugs and devices to diagnosis and treat orthostatic hypotension. Rising older population suffering from neurovascular disorders is a major factor boosting Orthostatic Hypotension Market Demand.
Technological advancement: Leading players are focusing on development of novel drug delivery systems, advance diagnostic tools, wearable medical devices and other technology-driven solutions to improve treatment effectiveness. This is helping address unmet needs and drive market growth.
Market Trends
Increasing adoption of combo drug therapy: Research trends suggests combination therapy using multiple drugs having different mechanisms is more effective than monotherapy. Key players are developing fixed-dose combination drugs for improved outcomes.
Focus on non-pharmacological treatment: With growing awareness, non-drug options like lifestyle modifications, wearing compression stockings and abdominal binders are gaining popularity. Companies are promoting such protocols.
Market Opportunities
Emerging economies: Markets in Asian and Latin American countries present high growth potential supported by rising healthcare expenditure, expanding patient pool and increasing diagnosis rates.
New product launches: With patents of major drugs expiring, players have opportunities to develop novel formulations, drug-device combination products and other differentiated offerings catering to unmet needs.
Impact of COVID-19 on Orthostatic Hypotension Market Growth
The COVID-19 pandemic has impacted the orthostatic hypotension market in several ways. During the initial months of the pandemic in 2020, the market experienced a reduction in growth owing to lockdowns and social distancing measures implemented globally. Many patient visits and consultation appointments were either cancelled or postponed which reduced the demand for diagnostic tests and treatment drugs. Manufacturing and supply chain activities were also scaled down due to lockdowns affecting the production and distribution of orthostatic hypotension drugs.
However, post pandemic recovery from 2021, the market is witnessing steady growth again. With resumption of healthcare facilities and lifting of restrictions, the number of patient visits has increased. This has boosted the demand for diagnostic evaluation and management of orthostatic hypotension cases. Moreover, the increased stress and anxiety levels during the pandemic have aggravated orthostatic hypotension symptoms in some patients who are more focused on seeking proper medical care and treatment. The growing geriatric population which is more susceptible to orthostatic hypotension has also supported market expansion.
Geographical Regions with Highest Orthostatic Hypotension Market Value
North America represents the largest regional market in terms of value for orthostatic hypotension globally. This is attributed to factors such as the rising elderly population affected by autonomic dysfunction leading to orthostatic hypotension. Furthermore, developed healthcare infrastructure, availability of advanced diagnostic facilities and effective reimbursement policies have aided market growth in the United States and Canada. Increased awareness levels regarding orthostatic hypotension as a condition have also boosted early diagnosis and treatment rates adding to the North American market revenue.
Region with Fastest Growth in Orthostatic Hypotension Market
The Asia Pacific region is projected to witness the fastest growth in the global orthostatic hypotension market during the forecast period. This is owing to large patient population pools and improving economic conditions leading to higher healthcare spending. Rising geriatric demographics, growing incidences of neurological disorders, diabetes and cardiovascular diseases causing orthostatic hypotension also contribute to market expansion. Increasing investments by leading players, healthcare reforms and widening insurance coverage are supporting regional market growth.
Get More Insights On- Orthostatic Hypotension Market
Get This Report in Japanese Language: 起立性低血圧市場
Get This Report in Korean Language: 기립성 저혈압 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek